These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7444853)

  • 1. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications.
    Butkus A; Skrinska VA; Schumacher OP
    Thromb Res; 1980 Jul 1-15; 19(1-2):211-23. PubMed ID: 7444853
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus.
    Lagarde M; Burtin M; Berciaud P; Blanc M; Velardo B; Dechavanne M
    Thromb Res; 1980 Sep; 19(6):823-30. PubMed ID: 7466751
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboxane generation and platelet aggregation in survivals of myocardial infarction.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzińska L; Serwońska M; Marcinkiewicz E
    Thromb Haemost; 1978 Aug; 40(1):66-74. PubMed ID: 725852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid.
    Driss F; Vericel E; Lagarde M; Dechavanne M; Darcet P
    Thromb Res; 1984 Dec; 36(5):389-96. PubMed ID: 6098051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of thromboxane A2 synthesis in platelet aggregation induced by factor VIII/von Willebrand factor.
    Kao KJ; Pizzo SV
    Thromb Res; 1981 Nov; 24(3):245-51. PubMed ID: 6801805
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus.
    Watanabe J; Umeda F; Wasada T; Ibayashi H
    Tohoku J Exp Med; 1984 Oct; 144(2):143-50. PubMed ID: 6515648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.
    Jackson CA; Greaves M; Patterson AD; Brown CB; Preston FE
    Br J Haematol; 1982 Sep; 52(1):69-77. PubMed ID: 6810912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary arachidonic acid supplementation increases thromboxane synthesizing activity in platelets from diabetics.
    Takahashi R; Morita I; Murota S; Shiraki M; Ito H; Orimo H
    Prostaglandins Leukot Med; 1983 Aug; 11(4):443-50. PubMed ID: 6413982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
    Chignard M; Vargaftig BB
    Biochem Pharmacol; 1978; 27(11):1603-6. PubMed ID: 29642
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
    Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E
    Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154
    [No Abstract]   [Full Text] [Related]  

  • 17. Interrelation of platelet vitamin E and thromboxane synthesis in type I diabetes mellitus.
    Karpen CW; Cataland S; O'Dorisio TM; Panganamala RV
    Diabetes; 1984 Mar; 33(3):239-43. PubMed ID: 6698315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation.
    Mehta J; Mehta P; Ostrowski N
    Clin Pharmacol Ther; 1983 Nov; 34(5):559-64. PubMed ID: 6627818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation.
    Lecompte T; Randon J; Chignard M; Vargaftig BB; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():441-7. PubMed ID: 6221560
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.
    Hornby EJ; Skidmore IF
    Biochem Pharmacol; 1982 Mar; 31(6):1158-60. PubMed ID: 7200773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.